<DOC>
	<DOCNO>NCT02220712</DOCNO>
	<brief_summary>To assess pharmacokinetics safety aripiprazole intra-muscular ( IM ) depot formulation patient schizophrenia repeat administration injection deltoid muscle total 5 dos 400 mg 4-week interval</brief_summary>
	<brief_title>A Multicenter Open-label Study Investigating Pharmacokinetics Safety Aripiprazole IM Depot Formulation ( OPC-14597 IMD ) During Repeated Administration Injection Into Deltoid Muscle Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Patients diagnosis schizophrenia define Diagnostic Statistical Manual ( DSM ) IVText Revision ( TR ) ( 295.30 , 295.10 , 295.20 , 295.90 , 295.60 ) Patients provide write informed consent ( If patient minor , write consent legal representative must obtain addition patient 's write informed consent . ) Patients , male female , age 18 year old , young 65 year , time obtain informed consent Patients body mass index 18.5 high low 35.0 Patients whose mental condition stable well maintain 2 week without change dosage regimen nonaripiprazole oral atypical antipsychotic monotherapy prior obtain inform consent Patients receive aripiprazole past Patients diagnosed mental disorder schizophrenia , define DSMIVTR criterion . Patients history complication diabetes . Patients hepatic , renal , cardiac , hematopoietic disorder . Female patient pregnant lactating , may possibly pregnant , wish become pregnant , male patient whose partner wish become pregnant . Patients drug allergy drug hypersensitivity Patients clozapine ineffective , patient respond clozapine , patient currently treat clozapine . Patients complication Parkinson 's Disease ( exclude druginduced Parkinsonism ) . Patients history complication neuroleptic malignant syndrome , rhabdomyolysis , tardive dyskinesia , paralytic ileus water intoxication . Patients history complication psychological behavioral abnormality associate use psychoactive substance ( abuse alcohol , narcotic , organic solvent , etc ) . Patients history complication suicide attempt selfinjury within 52 week prior obtain inform consent . Patients history complication convulsive disorder epilepsy . Patients history complication organic brain disorder include cerebrovascular disease . Patients history complication granulocytopenia agranulocytosis . Patients receive electroconvulsive therapy ( ECT ) within 12 week prior obtain inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Aripiprazole</keyword>
	<keyword>Deltoid</keyword>
</DOC>